LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.3750
+0.0150 (4.17%)
Oct 23, 2025, 3:21 PM EDT
4.17%
Market Cap45.46M
Revenue (ttm)23.24M
Net Income (ttm)3.57M
Shares Out121.22M
EPS (ttm)0.03
PE Ratio12.14
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume73,500
Average Volume47,812
Open0.3650
Previous Close0.3600
Day's Range0.3600 - 0.3800
52-Week Range0.2900 - 0.5300
Beta-0.29
RSI48.96
Earnings DateNov 25, 2025

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 186
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.